Take a Breath: Selecting a Device for Inhaled Product Development

Information

The future commercial success of any new inhaled medicine relies in a large part on the correct combination of formulation and device technology chosen for its delivery.

This presentation will benefit any drug developer considering an inhaled programme and aims to answer the following questions:

• How are development targets and success criteria set for inhaled products?

• What are the key factors influencing inhaled delivery platform selection?

• How can phase-appropriate device selection accelerate an inhaled development programme?

VECTURA GROUP PLCVectura integrates formulation, device and development capabilities to offer a broad range of services to help customers bring inhaled medicines to market. With expertise in powder and liquid formulations, advanced analytics, GMP manufacturing and a portfolio of proprietary device and formulation technologies, Vectura can help customers developing a wide range of small molecules, biologics, and complex combinations.

Registered attendees

Sabine Vanhooidonk

Key Account ManagerInforma Markets

Simon Kassas

Managing Director HealthcarePKG Group, LLC

Vivek Kumar

Biopharma Market Development ManagerSpectrum Chemical Mfg. Corp.

Take a Breath: Selecting a Device for Inhaled Product Development

Information

Registered attendees

Log in

Log in